About
Kostas joined +ND Capital's Lausanne office in 2018 and is CEO of EVIR Therapeutics, having spun out companies from EPFL and the University of Bern. He holds a PhD in Molecular Embryology.
Colleagues at +ND Capital
Alison Palmer
Vice President of the General Partner at +ND Capital
André Châtelain
Advisor at +ND Capital
Aymeric Sallin
Founder and CEO at +ND Capital
Carl Pabo
Advisor at +ND Capital
Cathleen O’Connor
Executive Assistant at +ND Capital
Eric Moessinger
Partner at +ND Capital
Gabriela Ecco
Principal at +ND Capital
Jonathan Nicholson
Executive Director of the General Partner at +ND Capital